383 related articles for article (PubMed ID: 19505930)
1. Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice.
Hirata A; Maeda N; Hiuge A; Hibuse T; Fujita K; Okada T; Kihara S; Funahashi T; Shimomura I
Cardiovasc Res; 2009 Oct; 84(1):164-72. PubMed ID: 19505930
[TBL] [Abstract][Full Text] [Related]
2. Contribution of glucocorticoid-mineralocorticoid receptor pathway on the obesity-related adipocyte dysfunction.
Hirata A; Maeda N; Nakatsuji H; Hiuge-Shimizu A; Okada T; Funahashi T; Shimomura I
Biochem Biophys Res Commun; 2012 Mar; 419(2):182-7. PubMed ID: 22326264
[TBL] [Abstract][Full Text] [Related]
3. Eplerenone prevented obesity-induced inflammasome activation and glucose intolerance.
Wada T; Ishikawa A; Watanabe E; Nakamura Y; Aruga Y; Hasegawa H; Onogi Y; Honda H; Nagai Y; Takatsu K; Ishii Y; Sasahara M; Koya D; Tsuneki H; Sasaoka T
J Endocrinol; 2017 Dec; 235(3):179-191. PubMed ID: 28855315
[TBL] [Abstract][Full Text] [Related]
4. Mineralocorticoid Receptor Blockade Improves Insulin Sensitivity in the Rat Heart and a Possible Molecular Mechanism.
Wang M; Li Y; Zhou K; Zhang G; Wang Y; Liu T; Zhang Y; Guo A; An Y
Cell Physiol Biochem; 2016; 39(3):860-70. PubMed ID: 27497962
[TBL] [Abstract][Full Text] [Related]
5. Adipocyte Mineralocorticoid Receptor Activation Leads to Metabolic Syndrome and Induction of Prostaglandin D2 Synthase.
Urbanet R; Nguyen Dinh Cat A; Feraco A; Venteclef N; El Mogrhabi S; Sierra-Ramos C; Alvarez de la Rosa D; Adler GK; Quilliot D; Rossignol P; Fallo F; Touyz RM; Jaisser F
Hypertension; 2015 Jul; 66(1):149-57. PubMed ID: 25966493
[TBL] [Abstract][Full Text] [Related]
6. Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis.
Caprio M; Fève B; Claës A; Viengchareun S; Lombès M; Zennaro MC
FASEB J; 2007 Jul; 21(9):2185-94. PubMed ID: 17384139
[TBL] [Abstract][Full Text] [Related]
7. Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines.
Guo C; Ricchiuti V; Lian BQ; Yao TM; Coutinho P; Romero JR; Li J; Williams GH; Adler GK
Circulation; 2008 Apr; 117(17):2253-61. PubMed ID: 18427128
[TBL] [Abstract][Full Text] [Related]
8. Adipose hypothermia in obesity and its association with period homolog 1, insulin sensitivity, and inflammation in fat.
Yamaoka M; Maeda N; Takayama Y; Sekimoto R; Tsushima Y; Matsuda K; Mori T; Inoue K; Nishizawa H; Tominaga M; Funahashi T; Shimomura I
PLoS One; 2014; 9(11):e112813. PubMed ID: 25397888
[TBL] [Abstract][Full Text] [Related]
9. Endothelial mineralocorticoid receptor activation mediates endothelial dysfunction in diet-induced obesity.
Schäfer N; Lohmann C; Winnik S; van Tits LJ; Miranda MX; Vergopoulos A; Ruschitzka F; Nussberger J; Berger S; Lüscher TF; Verrey F; Matter CM
Eur Heart J; 2013 Dec; 34(45):3515-24. PubMed ID: 23594590
[TBL] [Abstract][Full Text] [Related]
10. Dynamic changes of adiponectin and S100A8 levels by the selective peroxisome proliferator-activated receptor-gamma agonist rivoglitazone.
Hiuge-Shimizu A; Maeda N; Hirata A; Nakatsuji H; Nakamura K; Okuno A; Kihara S; Funahashi T; Shimomura I
Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):792-9. PubMed ID: 21233451
[TBL] [Abstract][Full Text] [Related]
11. Highly hydroxylated fullerene localizes at the cytoskeleton and inhibits oxidative stress in adipocytes and a subcutaneous adipose-tissue equivalent.
Xiao L; Aoshima H; Saitoh Y; Miwa N
Free Radic Biol Med; 2011 Oct; 51(7):1376-89. PubMed ID: 21684329
[TBL] [Abstract][Full Text] [Related]
12. NOD1 activation induces proinflammatory gene expression and insulin resistance in 3T3-L1 adipocytes.
Zhao L; Hu P; Zhou Y; Purohit J; Hwang D
Am J Physiol Endocrinol Metab; 2011 Oct; 301(4):E587-98. PubMed ID: 21693690
[TBL] [Abstract][Full Text] [Related]
13. Effect of peroxisome proliferator-activated receptor-alpha ligands in the interaction between adipocytes and macrophages in obese adipose tissue.
Toyoda T; Kamei Y; Kato H; Sugita S; Takeya M; Suganami T; Ogawa Y
Obesity (Silver Spring); 2008 Jun; 16(6):1199-207. PubMed ID: 18356826
[TBL] [Abstract][Full Text] [Related]
14. Dysregulated glutathione metabolism links to impaired insulin action in adipocytes.
Kobayashi H; Matsuda M; Fukuhara A; Komuro R; Shimomura I
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1326-34. PubMed ID: 19366877
[TBL] [Abstract][Full Text] [Related]
15. Adipocyte-derived factors regulate vascular smooth muscle cells through mineralocorticoid and glucocorticoid receptors.
Nguyen Dinh Cat A; Briones AM; Callera GE; Yogi A; He Y; Montezano AC; Touyz RM
Hypertension; 2011 Sep; 58(3):479-88. PubMed ID: 21788604
[TBL] [Abstract][Full Text] [Related]
16. Cilostazol ameliorates systemic insulin resistance in diabetic db/db mice by suppressing chronic inflammation in adipose tissue via modulation of both adipocyte and macrophage functions.
Wada T; Onogi Y; Kimura Y; Nakano T; Fusanobori H; Ishii Y; Sasahara M; Tsuneki H; Sasaoka T
Eur J Pharmacol; 2013 May; 707(1-3):120-9. PubMed ID: 23528355
[TBL] [Abstract][Full Text] [Related]
17. PKC-delta-dependent activation of oxidative stress in adipocytes of obese and insulin-resistant mice: role for NADPH oxidase.
Talior I; Tennenbaum T; Kuroki T; Eldar-Finkelman H
Am J Physiol Endocrinol Metab; 2005 Feb; 288(2):E405-11. PubMed ID: 15507533
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of glucose-6-phosphate dehydrogenase is associated with lipid dysregulation and insulin resistance in obesity.
Park J; Rho HK; Kim KH; Choe SS; Lee YS; Kim JB
Mol Cell Biol; 2005 Jun; 25(12):5146-57. PubMed ID: 15923630
[TBL] [Abstract][Full Text] [Related]
19. The effects of aldosterone on diet-induced fatty liver formation in male C57BL/6 mice: comparison of adrenalectomy and mineralocorticoid receptor blocker.
Gamliel-Lazarovich A; Raz-Pasteur A; Coleman R; Keidar S
Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1086-92. PubMed ID: 23524523
[TBL] [Abstract][Full Text] [Related]
20. Mineralocorticoid receptor blockade prevents vascular remodelling in a rodent model of type 2 diabetes mellitus.
Silva MA; Cau SB; Lopes RA; Manzato CP; Neves KB; Bruder-Nascimento T; Mestriner FL; Montezano AC; Nguyen Dinh Cat A; Touyz RM; Tostes RC
Clin Sci (Lond); 2015 Oct; 129(7):533-45. PubMed ID: 25967696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
